Drugs / recombinant human stem cell factor
recombinant human stem cell factor
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00003957 Background | Dec 1998 → Sep 2000 | lymphoma | Fox Chase Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant human stem cell factor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003957 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human stem cell factor” NCT00003957 ↗ |
| Route | Subcutaneous | “Filgrastim (G-CSF) and stem cell factor (SCF) are administered subcutaneously” NCT00003957 ↗ |